(Q45366674)

English

CD20-negative Epstein-Barr virus-associated post-transplant lymphoproliferative disease refractory to rituximab in a patient with severe aplastic anemia.

scientific article published on 11 May 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559814%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

CD20-negative Epstein-Barr virus-associated post-transplant lymphoproliferative disease refractory to rituximab in a patient with severe aplastic anemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559814%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

based on heuristic

inferred from title

Epstein–Barr virus

0 references

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559814%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author name string

Hideki Muramatsu

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559814%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Yoshiyuki Takahashi

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559814%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Yoshie Shimoyama

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559814%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Sayoko Doisaki

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559814%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Nobuhiro Nishio

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559814%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Yoshinori Ito

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559814%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Asahito Hama

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559814%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Hiroshi Yagasaki

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559814%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Masafumi Ito

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559814%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Seiji Kojima

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559814%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

publication date

11 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559814%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

International Journal of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559814%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

93

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559814%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559814%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

779-781

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21559814%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

https://scigraph.springernature.com/pub.10.1007/s12185-011-0870-3

0 references

Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases

1 reference

https://api.crossref.org/works/10.1007%2FS12185-011-0870-3

21 January 2018

Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance

1 reference

https://api.crossref.org/works/10.1007%2FS12185-011-0870-3

21 January 2018

Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance

1 reference

https://api.crossref.org/works/10.1007%2FS12185-011-0870-3

21 January 2018

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS12185-011-0870-3

21 January 2018

Chimaeric anti-CD20 monoclonal antibody (rituximab) in post-transplant B-lymphoproliferative disorder following stem cell transplantation in children.

1 reference

https://api.crossref.org/works/10.1007%2FS12185-011-0870-3

21 January 2018

Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS12185-011-0870-3

21 January 2018

Preemptive Therapy of EBV-Related Lymphoproliferative Disease after Pediatric Haploidentical Stem Cell Transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS12185-011-0870-3

21 January 2018

CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21559814

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45366674&oldid=1562578204"